Results 261 to 270 of about 314,046 (312)
Some of the next articles are maybe not open access.

Felodipine in ventricular dysfunction

European Heart Journal, 1986
The systemic and coronary haemodynamic effects of felodipine were evaluated at rest and during stress induced atrial pacing in fourteen patients with chronic cardiac failure, secondary to coronary heart disease. Felodipine was an effective arteriolar vasodilator producing increases in cardiac index from 2.6 +/- 0.1 to 3.5 +/- 0.2 l min-1 m-2 (P less ...
A C, Tweddel, I, Hutton
openaire   +2 more sources

Right ventricular dysfunction

Current Opinion in Internal Medicine, 2007
Until recently the right ventricle's role in myocardial dynamics has not been fully appreciated. This article provides an overview of the pathophysiology, imaging and management of right ventricular dysfunction.That levosimendan may promote right ventricular function opens new avenues for treatment.
Justin, Woods   +2 more
openaire   +2 more sources

Ventricular compliance in ischemic right ventricular dysfunction

The American Journal of Cardiology, 1980
Ischemic right ventricular dysfunction was diagnosed in 54 patients with acute myocardial infarction who had a right atrial pressure disproportionately increased in relation to the pulmonary capillary pressure. The right atrial pressure curve in 40 patients (74 percent) was M- or W-shaped, termed a noncompliant pattern, and was similar to the pattern ...
I, Coma-Canella, J, Lopez-Sendon
openaire   +2 more sources

Ischemic right ventricular dysfunction

Cardiovascular Drugs and Therapy, 1994
For many years ischemic heart disease involving the right ventricle had received little attention. During the last 15 years, the initial works of Cohn, Isner, and others spawned a number of clinical and experimental studies that extended the understanding of the pathophysiology of ischemia in the right ventricle.
J, López-Sendón   +2 more
openaire   +2 more sources

Reversible Left Ventricular Dysfunction

Echocardiography, 2000
The extent and degree of myocardial viability are important parameters in the risk stratification of patients with significant left ventricular dysfunction secondary to coronary artery disease. Although several imaging modalities can identify viable myocardium, dobutamine stress echocardiography has gained considerable importance as an accurate, safe ...
F A, Chaudhry, B, Singh, K, Galatro
openaire   +2 more sources

Perioperative right ventricular dysfunction

Current Opinion in Anaesthesiology, 2013
To evaluate new information on the importance of right ventricular function, diagnosis and management in cardiac surgical patients.There is growing evidence that right ventricular function is a key determinant in survival in cardiac surgery, particularly in patients with pulmonary hypertension.
André Yvan, Denault   +3 more
openaire   +2 more sources

Management of perioperative ventricular dysfunction

Journal of Cardiothoracic and Vascular Anesthesia, 2001
With the recognition of the clinical importance of the right ventricle; the development of new techniques for the perioperative evaluation of RV function, particularly transesophageal echocardiography; and new treatment modalities (pharmacologic and mechanical), clinicians will be able to more accurately diagnose and precisely manage patients who have ...
M J, Griffin, R L, Hines
openaire   +2 more sources

Left-ventricular dysfunction

The Lancet, 1998
SIR—Theresa McDonagh (Sept 20, p 829) and Martin Cowie (Nov 8, p 1349) and their colleagues highlight some of the difficulties associated with the diagnosis and treatment of patients with impaired ventricular function. In the Glasgow study (McDonagh), a total of 43 individuals had echocardiographic evidence of an ejection fraction of 30% or less out of
Heribert Schunkert   +4 more
  +4 more sources

Soluble ST2 in Ventricular Dysfunction

2015
Heart failure is a commonly encountered condition associated with increased morbidity, mortality, and healthcare cost. For years, its management has been strongly influenced by the use of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide biomarkers. In some cases, this approach does not always identify patients with heart failure
Silvia, Lupu, Lucia, Agoston-Coldea
openaire   +2 more sources

Home - About - Disclaimer - Privacy